£72.71

Springer Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£73 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£73.50 £72.63 £72.82 £73.01 £73.20 £73.39 £73.58 09 March 2026 31 March 2026 22 April 2026 14 May 2026 06 June 2026

Price Distribution

Price distribution over 90 days • 1 price levels

Days at Price
90 days 0 23 45 68 90 £73 Days at Price

Price Analysis

Most common price: £73 (90 days, 100.0%)

Price range: £73 - £73

Price levels: 1 different prices over 90 days

Description

This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact.   Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed.   The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure–activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist.   Demonstrating that it is possible to develop compounds that convert into their inactive forms under environmental conditions, this book is useful for anyone interested in therapeutic agents with reduced environmental impact. Review From the Back Cover This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact.   Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed.   The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure–activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist.   Demonstrating that it is possible to develop compounds that convert into their inactive forms under environmental conditions, this book is useful for anyone interested in therapeutic agents with reduced environmental impact.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
24 January 2021
Listed Since
28 December 2020

Barcode

No barcode data available

Similar Products You Might Like

Proteinkinase Inhibitors: 36 (Topics in Medicinal Chemistry, 36)
80% match

Proteinkinase Inhibitors: 36 (Topics in Medicinal Chemistry, 36)

Springer

£100.08 06 Jun 2026
Development of a New Heterocycle-Forming Reaction and Kinetic Resolution with N-Heterocyclic Carbenes (Springer Theses)
79% match

Development of a New Heterocycle-Forming Reaction and Kinetic Resolution with N-Heterocyclic Carbenes (Springer Theses)

Springer

£73.01 25 May 2026
Applications of Nanotechnology for Green Synthesis (Nanotechnology in the Life Sciences)
78% match

Applications of Nanotechnology for Green Synthesis (Nanotechnology in the Life Sciences)

Springer

£123.45 31 May 2026
Atypical Elements in Drug Design: 17 (Topics in Medicinal Chemistry, 17)
78% match

Atypical Elements in Drug Design: 17 (Topics in Medicinal Chemistry, 17)

Springer

£140.71 25 May 2026
Tactics in Contemporary Drug Design: 9 (Topics in Medicinal Chemistry, 9)
78% match

Tactics in Contemporary Drug Design: 9 (Topics in Medicinal Chemistry, 9)

Springer

£135.68 06 Jun 2026
Reducing Drug Attrition: 11 (Topics in Medicinal Chemistry, 11)
78% match

Reducing Drug Attrition: 11 (Topics in Medicinal Chemistry, 11)

Springer

£107.98 25 May 2026
The Double [3+2] Photocycloaddition Reaction (Springer Theses)
78% match

The Double [3+2] Photocycloaddition Reaction (Springer Theses)

Springer

£76.38 31 May 2026
Visible Light Photocatalyzed Redox-Neutral Organic Reactions and Synthesis of Novel Metal-Organic Frameworks (Springer Theses)
77% match

Visible Light Photocatalyzed Redox-Neutral Organic Reactions and Synthesis of Novel Metal-Organic Frameworks (Springer Theses)

Springer

£74.72 05 Jun 2026
Development of Chemistry-Based Screening Platform for Access to Mirror-Image Library of Natural Products (Springer Theses)
77% match

Development of Chemistry-Based Screening Platform for Access to Mirror-Image Library of Natural Products (Springer Theses)

Springer

£72.71 03 Jun 2026
Transformation Products of Synthetic Chemicals in the Environment: 2 / 2P (The Handbook of Environmental Chemistry, 2 / 2P)
77% match

Transformation Products of Synthetic Chemicals in the Environment: 2 / 2P (The Handbook of Environmental Chemistry, 2 / 2P)

Springer

£64.00 27 May 2026
RNA Therapeutics: 27 (Topics in Medicinal Chemistry, 27)
77% match

RNA Therapeutics: 27 (Topics in Medicinal Chemistry, 27)

Springer

£243.89 05 Jun 2026
Structure-based Drug Discovery
77% match

Structure-based Drug Discovery

Springer

£76.38 29 May 2026
Medicinal Chemistry of Bioactive Natural Products
77% match

Medicinal Chemistry of Bioactive Natural Products

Wiley

£103.01 24 May 2026
Bioactive Natural products in Drug Discovery
77% match

Bioactive Natural products in Drug Discovery

Springer

£77.33 05 Jun 2026
Formulation, Characterization, and Stability of Protein Drugs: Case Histories: 9 (Pharmaceutical Biotechnology, 9)
77% match

Formulation, Characterization, and Stability of Protein Drugs: Case Histories: 9 (Pharmaceutical Biotechnology, 9)

Springer

£58.02 04 Jun 2026
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (Wiley Series in Drug Discovery and Development)
77% match

Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (Wiley Series in Drug Discovery and Development)

Wiley

£125.00 03 Jun 2026
Human Pharmaceuticals in the Environment: Current and Future Perspectives: 4 (Emerging Topics in Ecotoxicology, 4)
77% match

Human Pharmaceuticals in the Environment: Current and Future Perspectives: 4 (Emerging Topics in Ecotoxicology, 4)

Springer

£74.41 25 May 2026
Advanced Nanostructured Materials for Environmental Remediation: 25 (Environmental Chemistry for a Sustainable World, 25)
77% match

Advanced Nanostructured Materials for Environmental Remediation: 25 (Environmental Chemistry for a Sustainable World, 25)

Springer

£112.13 26 May 2026
Fungi Bioactive Metabolites: Integration of Pharmaceutical Applications
77% match

Fungi Bioactive Metabolites: Integration of Pharmaceutical Applications

Springer

£107.07 01 Jun 2026
Small Molecule Therapeutics for Schizophrenia: 13 (Topics in Medicinal Chemistry, 13)
77% match

Small Molecule Therapeutics for Schizophrenia: 13 (Topics in Medicinal Chemistry, 13)

Springer

£76.38 31 May 2026
Rational Design of Stable Protein Formulations: Theory and Practice: 13 (Pharmaceutical Biotechnology, 13)
77% match

Rational Design of Stable Protein Formulations: Theory and Practice: 13 (Pharmaceutical Biotechnology, 13)

Springer

£107.78 03 Jun 2026
Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles: Volume 17 (Chemical Biology)
77% match

Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles: Volume 17 (Chemical Biology)

Royal Society of Chemistry

£121.88 22 May 2026
The Smoothened Receptor in Cancer and Regenerative Medicine: 16 (Topics in Medicinal Chemistry, 16)
77% match

The Smoothened Receptor in Cancer and Regenerative Medicine: 16 (Topics in Medicinal Chemistry, 16)

Springer

£141.22 02 Jun 2026
Strategies for Organic Drug Synthesis and Design
77% match

Strategies for Organic Drug Synthesis and Design

Wiley

£117.00 06 Jun 2026